NCT00667849

Brief Summary

The purpose of this study is to determine the effect of low-intensity, pulsed ultrasound on tibial fractures treated with intramedullary nailing.

Trial Health

60
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
501

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2008

Longer than P75 for not_applicable

Geographic Reach
2 countries

16 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 21, 2008

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 28, 2008

Completed
4 months until next milestone

Study Start

First participant enrolled

September 1, 2008

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2012

Completed
3 years until next milestone

Results Posted

Study results publicly available

December 8, 2015

Completed
Last Updated

December 8, 2015

Status Verified

November 1, 2015

Enrollment Period

4.3 years

First QC Date

April 21, 2008

Results QC Date

September 24, 2015

Last Update Submit

November 4, 2015

Conditions

Keywords

Tibia

Outcome Measures

Primary Outcomes (2)

  • Change From Baseline in the SF-36 Physical Component Summary (PCS) Score of the Short Form-36 (SF-36)

    Assessments at baseline and 6 post baseline time points/ mixed effects repeated measure single point estimate. Range= -100 worst, 0 best

    Over 365 days

  • Time (Days) to Radiographic Healing of Tibial Fractures

    Days from randomization to day of x-ray assessed healed or, if not healed, day of premature withdrawal/study termination or day 365 (end of study visit)/ Kaplan-Meier

    over 365 days

Other Outcomes (1)

  • Treatment Compliance

    Treatment period: Days from randomization to day of x-ray assessed healed or, if not heal, day of premature withdrawal/study termination or day 365 (end of study visit)

Study Arms (2)

Exogen 4000+

ACTIVE COMPARATOR

Single arm, Exogen 4000+

Device: Exogen 4000+

Sham

SHAM COMPARATOR

Single arm, sham (identical device with the exception of administration of ultrasound).

Device: Sham

Interventions

Low-intensity pulsed ultrasound (LIPUS)

Also known as: Exogen Bone Healing System - 4000+ series
Exogen 4000+
ShamDEVICE

sham device identical to active device with the exception of administration of ultrasound

Also known as: Single arm, sham of the Exogen 4000+
Sham

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Males and females age 18 years or older
  • Have an open or closed tibial fracture amenable to intramedullary nail fixation

You may not qualify if:

  • Tibial fracture associated with a vascular injury requiring repair
  • Pilon fractures
  • Tibial fractures that extend into the joint and require reduction
  • Pathologic fractures • Bilateral tibial fractures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (16)

San Francisco General/Dept of Orthopedic Surgery

San Francisco, California, 94110, United States

Location

Florida Orthopedic Institute

Tampa, Florida, 33606, United States

Location

OrthoIndy

Indianapolis, Indiana, 46202, United States

Location

University of Kentucky

Lexington, Kentucky, 50436, United States

Location

Eastern Maine Medical Center

Bangor, Maine, 04401, United States

Location

University of Missouri

Columbia, Missouri, 65212, United States

Location

Insall Scott Kelly Institute

New York, New York, 10065, United States

Location

Duke University Medical Center

Durham, North Carolina, 27710, United States

Location

Rothman Institute

Philadelphia, Pennsylvania, 19107, United States

Location

Temple University Hospital

Philadelphia, Pennsylvania, 19140, United States

Location

Greenville Hospital System

Greenville, South Carolina, 29605, United States

Location

Orthopedic Specialtiy Associates

Fort Worth, Texas, 76104, United States

Location

West Virginia University

Morgantown, West Virginia, 26506, United States

Location

Foothills Medical Centre

Calgary, Alberta, T2N 2T9, Canada

Location

Vancouver Coastal Health

Vancouver, British Columbia, V5Z 1M9, Canada

Location

QE II Health Sciences Centre

Halifax, Nova Scotia, Canada

Location

Related Publications (4)

  • Findakli F, Busse JW, Schemitsch EH, Lonn E, Farrokhyar F, Bhandari M; and the TRUST Investigators. Smoking, Obesity, and Disability Benefits or Litigation Are Not Associated with Clinically Important Reductions in Physical Functioning After Intramedullary Nailing of Tibial Shaft Fractures: A Retrospective Cohort Study. Clin Orthop Relat Res. 2021 Apr 1;479(4):805-813. doi: 10.1097/CORR.0000000000001573.

  • TRUST Investigators writing group; Busse JW, Bhandari M, Einhorn TA, Schemitsch E, Heckman JD, Tornetta P 3rd, Leung KS, Heels-Ansdell D, Makosso-Kallyth S, Della Rocca GJ, Jones CB, Guyatt GH. Re-evaluation of low intensity pulsed ultrasound in treatment of tibial fractures (TRUST): randomized clinical trial. BMJ. 2016 Oct 25;355:i5351. doi: 10.1136/bmj.i5351.

  • Busse JW, Bhandari M, Einhorn TA, Heckman JD, Leung KS, Schemitsch E, Tornetta P 3rd, Walter SD, Guyatt GH. Trial to re-evaluate ultrasound in the treatment of tibial fractures (TRUST): a multicenter randomized pilot study. Trials. 2014 Jun 4;15:206. doi: 10.1186/1745-6215-15-206.

  • Dijkman BG, Busse JW, Walter SD, Bhandari M; TRUST Investigators. The impact of clinical data on the evaluation of tibial fracture healing. Trials. 2011 Nov 3;12:237. doi: 10.1186/1745-6215-12-237.

MeSH Terms

Conditions

Tibial Fractures

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and InjuriesLeg Injuries

Limitations and Caveats

Poor Compliance: Protocol defined compliance as ≥18 minutes use per day. Devices have a treatment monitor that showed average compliance of 42.3% (sham) and 44.6% (active) in 80% of treatment days. Poor treatment adherence confounds results.

Results Point of Contact

Title
Peter Heeckt, MD (CMO)
Organization
Bioventus LLC

Study Officials

  • Mohit Bhandari, MD

    McMaster University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 21, 2008

First Posted

April 28, 2008

Study Start

September 1, 2008

Primary Completion

December 1, 2012

Study Completion

December 1, 2012

Last Updated

December 8, 2015

Results First Posted

December 8, 2015

Record last verified: 2015-11

Locations